Advanced Malignant Solid Neoplasm
Showing 26 - 50 of 93
Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Locally Advanced Malignant Solid Neoplasm
- Binimetinib
- +22 more
- (no location specified)
Dec 2, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States
Recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +7 more
-
Aurora, Colorado
- +7 more
Nov 29, 2022
Advanced Malignant Solid Tumor, Anal Carcinoma, HIV Infection Trial in Australia, United States (Ipilimumab, Nivolumab)
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Ipilimumab
- Nivolumab
-
La Jolla, California
- +34 more
Nov 29, 2022
Advanced Malignant Tumor, Cancer Fatigue, Metastatic Malignant Tumor Trial in Houston (drug, behavioral, other)
Recruiting
- Advanced Malignant Solid Neoplasm
- +4 more
- Dexamethasone
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 3, 2022
Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor
Recruiting
- Advanced Malignant Solid Neoplasm
- +7 more
- BET Bromodomain Inhibitor ZEN-3694
- Talazoparib
-
Atlanta, Georgia
- +2 more
Nov 3, 2022
Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,
Recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 25, 2022
Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose
Recruiting
- Advanced Malignant Solid Neoplasm
- +5 more
- RSC-1255 Dose Escalation
- RSC-1255 Dose Expansion
-
Los Angeles, California
- +5 more
Oct 24, 2022
Advanced Malignant Solid Tumor, C-Reactive Protein Measurement, Cancer Fatigue Trial in Houston (drug, behavioral, other)
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +5 more
- Anamorelin Hydrochloride
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor, Refractory Ovarian Carcinoma Trial in Houston (TRPV6 Calcium
Recruiting
- Advanced Malignant Solid Neoplasm
- +22 more
- TRPV6 Calcium Channel Inhibitor SOR-C13
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
- Pharmacokinetic Study
- Ulixertinib
-
Birmingham, Alabama
- +108 more
Oct 19, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- CDK Inhibitor AT7519
- +3 more
-
Washington, District of Columbia
- +5 more
Oct 18, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,
Suspended
- Advanced Malignant Solid Neoplasm
- +4 more
- BET Bromodomain Inhibitor ZEN-3694
- Binimetinib
-
Boston, Massachusetts
- +2 more
Oct 5, 2022
Distress Associated With Coronavirus Disease 2019 and Telehealth
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +6 more
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Sep 16, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
- Pharmacodynamic Study
- Telaglenastat Hydrochloride
-
Birmingham, Alabama
- +30 more
Sep 1, 2022
Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)
Recruiting
- Advanced Malignant Solid Neoplasm
- +6 more
-
Costa Mesa, California
- +49 more
Aug 24, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +32 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +124 more
Aug 24, 2022
Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +30 more
- Larotrectinib Sulfate
-
Birmingham, Alabama
- +123 more
Aug 23, 2022
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Trametinib
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Trametinib Dimethyl Sulfoxide
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Aug 13, 2022
Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,
Recruiting
- Advanced Bile Duct Carcinoma
- +33 more
- Cisplatin
- +2 more
-
Sacramento, California
- +6 more
Aug 11, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor Trial in Philadelphia (Biopsy,
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Biopsy
- +3 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Aug 5, 2022
Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Imatinib Mesylate
- Ipilimumab
-
Houston, TexasM D Anderson Cancer Center
Aug 1, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Capivasertib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Adoption of Audio Recording in Outpatient Supportive Care Center
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +4 more
- Communication Intervention
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (Best Practice, Chart
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
- Best Practice
- +6 more
- (no location specified)
Jul 12, 2022